SCHEMBL7666947

SCHEMBL7666947

CCCc1cnc(-c2cccc(Oc3ccccc3)c2OC(C)C)cn1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ FEN1 P39748 6/20 0.38
▸ ALOX5AP P20292 5/20 0.38
▸ BCL2L2 Q92843 2/20 0.36
▸ FYN P06241 2/20 0.34
▸ POLB P06746 3/20 0.33
▸ ATM Q13315 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ MAPT P10636 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ ABL1 P00519 1/20 0.32
▸ GABRA1 P14867 1/20 0.31
▸ GABRG2 P18507 1/20 0.31
▸ GABRB3 P28472 1/20 0.31
▸ GABRA5 P31644 1/20 0.31
▸ GABRA3 P34903 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ PTGS2 P35354 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7664066 0.84 BCL2L2 (0.37) FEN1ALOX5APBCL2L2FYNPOLB
SCHEMBL7664751 0.77 HTR2A (0.40) FEN1ALOX5APBCL2L2POLBATM
SCHEMBL7664372 0.74 PLAU (0.41) L3MBTL1MAPTHTTNPSR1MEN1
SCHEMBL7670839 0.74 CYP11B1 (0.41) BCL2L2POLBATMMAPTMEN1
SCHEMBL7666933 0.74 CYP11B1 (0.42) FEN1BCL2L2
SCHEMBL7668578 0.73 L3MBTL1 (0.36) FEN1ALOX5APL3MBTL1MAPTNPSR1
SCHEMBL7672934 0.72 TTR (0.34) FEN1ALOX5APBCL2L2FYNPOLB
SCHEMBL7664578 0.72 GRM5 (0.38) FEN1MAPT
SCHEMBL7673906 0.71 KEAP1 (0.39) L3MBTL1MAPTHTTNPSR1MEN1
SCHEMBL19612344 0.69 NPSR1 (0.43) POLBL3MBTL1HTTNPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 — — US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 — — US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 — — US disclosed
Send feedback